Advertisement

Reactions Weekly

, Volume 1780, Issue 1, pp 21–21 | Cite as

Aldesleukin/programmed-cell-death-1-receptor-antagonists

Various toxicities: 7 case reports
Case report
  • 73 Downloads

Reference

  1. Rafei-Shamsabadi D, et al. Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone. Cancer Immunology Immunotherapy 68: 1417-1428, No. 9, Sep 2019. Available from: URL: http://doi.org/10.1007/s00262-019-02377-x - GermanyCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations